Ten National and Regional Ontario Genomics Projects are Part of $20 Million Funding Package

Ten new Ontario Genomics projects are part of the Canadian government’s $20 million investment in 34 biotech R&D commercialization initiatives across the country. Stemming from the Canadian Genomics Strategy, these national and regional Genomic Applications Partnership Program (GAPP) projects are advancing precision healthcare, cleantech and food safety in a variety of ways.

Congratulations to the four OBIO-affiliated companies; Neuropeutics, PhenoTips, ProteinQure, and Specific Biologics selected among the Ontario Genomics projects.